Please assess the completion status of the following clinical trial:

Trial Title: Trunk Motor Control Performance Before and After Spinal Manipulation Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~All participants must meet all of the inclusion criteria to participate in the study. Below is a list of inclusion criteria for ALL participants:~* Age 21-65 years~* Independently ambulatory~* Able to speak and read English~* Able to understand study procedures and to comply with them for the entire length of the study.~Below is an additional list of inclusion criteria for low back pain participants:~* Willing to be randomized to either immediate or delayed treatment group.~* Musculoskeletal pain - primarily in the lumbar region~* Pain rating greater or equal to 3 out of 10 as indicated on the Numeric Rating Scale for Pain~* Back Disability greater or equal to 26% as indicated on the Oswestry Disability Index~Exclusion Criteria:~All candidates meeting any of the exclusion criteria at baseline will be excluded from study participation. Exclusion criteria will be self-reported. However, during each treatment session, the physicians will be watching for clinical signs and symptoms not consistent with physical findings that are suggestive of the presence of any of the exclusion criteria. In such a case, further treatment will be discontinued and the subject will be excluded.~Below is a list of exclusion criteria for ALL participants:~* Inability or unwillingness of individual to give written informed consent.~* Physical therapy or any other form of manual medicine (e.g., Osteopathic Manipulative Medicine, Chiropractic Manipulation, etc.), acupuncture or spinal injections within one month prior to study enrollment~* Workers' compensation benefits in the past 3 months or ongoing medical legal issues~* Possibly pregnant~* Extreme obesity (BMI\>36)~* Currently using electrical implants (e.g., cardiac pacemakers, drug delivery pumps, etc.)~History of:~* Spinal surgery~* Spinal fracture~* Spinal infection (e.g., osteomyelitis)~* Cancer~Unresolved symptoms from:~* Head trauma~* Inner ear infection with associated balance and coordination problems~* Orthostatic hypotension~* Uncontrolled hypertension~* Vestibular disorder (e.g. vertigo)~Current diagnosis of:~* Significant spinal deformity (e.g., scoliosis \> 20 degrees, torticollis)~* Ankylosing spondylitis~* Spondylolisthesis grades III or IV~* Cauda equine syndrome~* Rheumatoid arthritis~* Osteoporosis~* Angina or congestive heart failure symptoms~* Active bleeding or infection in the back~* Blindness~* Seizures~* Neurologic disease (e.g., Parkinson's disease, multiple sclerosis, cerebral palsy, Alzheimer's disease, amyotrophic lateral sclerosis, stroke or transient ischemic attack in the past year, cervical dystonia)~Conditions recognized by a physician any time during the study:~* Significant or worsening signs of neurologic deficit~* Symptoms are not consistent with mechanical findings~* Other conditions impeding protocol implementation~Below is an additional exclusion criterion for healthy control participants:~• Based on the minimal clinically important difference of 2 points (Childs et al., 2005), healthy controls with 2 points or greater pain on NRS will not be eligible to participate.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Immediate treatment (Type: EXPERIMENTAL): This arm receives spinal manipulation treatment shortly after enrollment
- Delayed treatment (Type: EXPERIMENTAL): This arm receives spinal manipulation treatment approximately 4 weeks after enrollment
- Healthy control (no low back pain) (Type: NO_INTERVENTION): In this arm, healthy controls are tested at baseline.

Based on this trial design, predict the completion outcome and termination type (if applicable).